| | | | |

Pain a Sign of Successful Pleurodesis for Mesothelioma, Study Says

pleurodesis for mesothelioma
attractive older man with head on hand

A temporary increase in pain may be a sign of success when undergoing pleurodesis for mesothelioma-related lung fluid.

An uncomfortable build-up of lung fluid is one of the most common and life-limiting mesothelioma symptoms

Chemical pleurodesis is one way doctors treat the problem. About three out of four patients have good luck with pleurodesis for mesothelioma. Now, a new study from the UK suggests that those who have the best results with the procedure also tend to have the most pain afterward. 

What is Pleurodesis for Mesothelioma?

Pleural mesothelioma is a malignancy that starts in the layers of the pleura. The pleura is a membrane that surrounds the lungs. 

When tumors grow in the pleural membrane, they can trigger a build-up of fluid between the lungs and the membrane. This fluid is called pleural effusion. Pleural effusion puts pressure on the lungs and makes it hard to breathe. 

Pleurodesis for mesothelioma is a popular way to treat pleural effusion. It involves filling the space between the lungs and the pleura with a chemical irritant like talc. The irritant causes inflammation which closes off the space. 

After successful pleurodesis for mesothelioma, there is no longer any space for fluid to collect.   

What Pain Level Says About Treatment Success

The new study of pleurodesis for mesothelioma and other cancers included 285 UK patients. Patients had an overall pleurodesis success rate of 81 percent. 

Researchers compared the pain levels of people who underwent pleurodesis. They found that those who had the biggest change in their cancer pain during the process had the most success with the procedure.

“There was a significantly higher rise in CRP [cancer-related pain] in the Pleurodesis Success group compared with the Pleurodesis Failure group,” writes Dr. Rachel Mercer. Mercer is with the Oxford Centre for Respiratory Medicine.

Mercer and her colleagues say the pain probably comes from the inflammation happening in the pleural membrane. How much the pain level changed in patients was more closely linked to success than the level of the pain itself. 

Pleurodesis is Not the Only Option

Unfortunately, the team also found that people who had pleurodesis for mesothelioma had a lower rate of success than other types of cancer patients. The researchers say this is probably because there is less healthy pleural tissue to start with. 

A pleural catheter is another option for treating pleural effusion. Doctors implant a catheter to drain off excess fluid as it collects. When it works, pleurodesis for mesothelioma is a longer-lasting solution to the problem. 

An estimated 80 to 95 percent of mesothelioma patients have pleural effusion by the time they receive a diagnosis. 

Source:

Mercer, RM, et al, “Clinically important associations of pleurodesis success in malignant pleural effusion: Analysis of the TIME1 data set”, December 17, 2019, Respirology, Epub ahead of print, https://onlinelibrary.wiley.com/doi/abs/10.1111/resp.13755

Similar Posts

  • | |

    Doctors Describe "Concrete Therapeutic Approach" for Mesothelioma

    A team of medical researchers in Italy have achieved what they are calling “excellent” tumor control and survival results in malignant pleural mesothelioma patients using a combination of surgery, chemotherapy, and radiotherapy. Caused by exposure to asbestos, mesothelioma typically spreads quickly across the lung-encasing membrane called the pleura. There is no known cure but treatments are improving. In the current prospective study, 20 malignant pleural mesothelioma patients underwent radical pleurectomy/decortication followed by high doses of radiation. After surgeons removed as much of the visible mesothelioma tumor and surrounding tissue as possible, patients received 50Gy of radiation to the effected side of their chest, delivered in 25 fractions. Regions of particular concern for mesothelioma regrowth got an extra radiation “boost” to…

  • |

    Mesothelioma Still Rising Despite Ban in Ireland

    A study in Ireland confirms that it can take many years for a ban on asbestos to have a measurable impact on a country’s rates of malignant mesothelioma. Mesothelioma is the most serious of a list of diseases – including lung cancer, pleural plaques, asbestosis, and others – linked with exposure to asbestos dust. Affecting the linings around the lungs and other organs, mesothelioma is often resistant to most cancer treatments and may be fatal within a year of diagnosis. According to the International Ban Asbestos Secretariat, Ireland is one of 55 countries that have enacted some type of asbestos ban. However, although Ireland banned asbestos in 2000, a new study published in Cancer Epidemiology shows that incidence of the…

  • | |

    Does Radiotherapy Reduce Mesothelioma Pain?

    A new study says there is not enough evidence to support the use of radiotherapy for the treatment of pain associated with malignant pleural mesothelioma. Researchers at the University of Edinburgh in Scotland reviewed a range of past studies on mesothelioma pain and radiotherapy by searching databases that date back as far as 1974. To be eligible to be included in their review, the study had to focus on malignant pleural mesothelioma and radiotherapy given “with the intent of improving pain”. The study also had to report doses and fractionation of the radiotherapy and how the pain responded. In all, the researchers found eight studies on mesothelioma pain and radiotherapy that met the criteria. Two of the studies were prospective…

  • |

    Website Aims to Protect Homeowners from Mesothelioma

    Australia’s Cancer Council is trying to educate home renovators about their risk for mesothelioma with a new e-learning course. Australia has one of the highest per capita rates of mesothelioma in the world, largely because of several asbestos mining operations that were once located there. Although asbestos has been banned from building products in Australia since 1989, asbestos-linked diseases like mesothelioma, lung cancer, and asbestosis continue to pose a serious health concern. While mesothelioma has traditionally occurred among people exposed to asbestos on the job, Australia is now bracing for another “wave” of mesothelioma victims among homeowners who encounter asbestos while doing their own renovation projects. Cancer Council Australia has launched “kNOw asbestos in your home” in an effort to…

  • |

    Ape Virus Shrinks Mesothelioma Tumors in Lab

    A virus that causes leukemia in gibbon apes may have the power to help fight malignant mesothelioma in people. Gibbon ape leukemia virus (GALV) has been tested for years as a viral vector, a carrier of therapeutic genetic information, in the treatment of various human illnesses, including cancer. A new study in Japan compared GALV with a leukemia virus derived from mice to see which carrier communicated most efficiently with mesothelioma cells. While both types of viruses replicated in most of the mesothelioma cell lines tested, the mouse-derived virus was not effective in a mesothelioma cell line called ACC-MESO-1. In this cell line, only the GALV spread efficiently both in culture and in mice that had been given human mesothelioma…

  • | |

    Radiotherapy for Mesothelioma: Better But Still Limited

    A form of highly-targeted radiation therapy for mesothelioma is better than it used to be, but is still risky. That is the message of a recent article on intensity-modulated radiation therapy (IMRT) in Seminars in Thoracic and Cardiovascular Surgery. Author Kenneth E. Rosenzweig, MD, a Radiation Oncologist with Mount Sinai Hospital in New York, reviewed recent studies on IMRT and mesothelioma. He concludes that, while the “troubling toxicity” associated with IMRT when it was first introduced has not been entirely eliminated, the fact that clinicians now have more experience with it is making a positive difference for mesothelioma patients. Before targeted therapies like IMRT were available, high-dose radiation was not usually a feasible option for mesothelioma since the irregular shape…